A Tale Of Two Committees: Which Probed EpiPen Better?
Executive Summary
If you were an FDA official, would you prefer to be a sideshow at a contentious House committee hearing or the focus of a cordial Senate one?
You may also be interested in...
Senate Drug Pricing Hearing Looms As Unparalleled Event For Pharma
From Vioxx to EpiPen, industry has been called in to testify before Congress on a range of issues. But with seven big pharma leaders having accepted the Senate Finance Committee's invitation Feb. 26, the stage is set for some exceptional political theater.
Senate Drug Pricing Hearing Looms As Unparalleled Event For Pharma
From Vioxx to EpiPen, industry has been called in to testify before Congress on a range of issues. But with seven big pharma leaders having accepted the Senate Finance Committee's invitation Feb. 26, the stage is set for some exceptional political theater.
FDA Hiring Campaign Continues; Goal Is Addressing Pending ANDAs
GDUFA funding will bring 50 additional people to the Office of Pharmaceutical Quality for generic drug review purposes.